Philip Roy Neubauer, MD | |
601 N Caroline St, Baltimore, MD 21287-0006 | |
(510) 955-5000 | |
Not Available |
Full Name | Philip Roy Neubauer |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 21 Years |
Location | 601 N Caroline St, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326187873 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | P18017 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Stella Maris Inc | Timonium, MD | Home health agency |
Mercy Medical Center Inc | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fine Bryant And Wah Inc | 0345237327 | 14 |
St Paul Place Specialists Inc | 7719882943 | 268 |
News Archive
As mothers continue having children later in life, it is inevitable that menopause will be delayed, and possibly cease to exist altogether, say researchers at McMaster University.
Verisk Health, Inc., and Carena, Inc. announced today that they have signed an agreement to join forces to improve healthcare outcomes and reduce medical costs. Verisk Health is a global leader in identifying, analyzing, and predicting healthcare risk. Carena, Inc. provides consumers with 24/7 medical care and education through its network of board-certified physicians and advanced registered nurse practitioners.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
A new evaluation of malaria rapid diagnostic tests will help health workers quickly identify which patients have the disease and need immediate treatment, putting into action recent World Health Organization recommendations to confirm diagnosis of malaria before treatment.
› Verified 6 days ago
Entity Name | St Paul Place Specialists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871549196 PECOS PAC ID: 7719882943 Enrollment ID: O20031202000084 |
News Archive
As mothers continue having children later in life, it is inevitable that menopause will be delayed, and possibly cease to exist altogether, say researchers at McMaster University.
Verisk Health, Inc., and Carena, Inc. announced today that they have signed an agreement to join forces to improve healthcare outcomes and reduce medical costs. Verisk Health is a global leader in identifying, analyzing, and predicting healthcare risk. Carena, Inc. provides consumers with 24/7 medical care and education through its network of board-certified physicians and advanced registered nurse practitioners.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
A new evaluation of malaria rapid diagnostic tests will help health workers quickly identify which patients have the disease and need immediate treatment, putting into action recent World Health Organization recommendations to confirm diagnosis of malaria before treatment.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Philip Roy Neubauer, MD 817 Wiseburg Rd, White Hall, MD 21161-9407 Ph: (510) 955-5000 | Philip Roy Neubauer, MD 601 N Caroline St, Baltimore, MD 21287-0006 Ph: (510) 955-5000 |
News Archive
As mothers continue having children later in life, it is inevitable that menopause will be delayed, and possibly cease to exist altogether, say researchers at McMaster University.
Verisk Health, Inc., and Carena, Inc. announced today that they have signed an agreement to join forces to improve healthcare outcomes and reduce medical costs. Verisk Health is a global leader in identifying, analyzing, and predicting healthcare risk. Carena, Inc. provides consumers with 24/7 medical care and education through its network of board-certified physicians and advanced registered nurse practitioners.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
A new evaluation of malaria rapid diagnostic tests will help health workers quickly identify which patients have the disease and need immediate treatment, putting into action recent World Health Organization recommendations to confirm diagnosis of malaria before treatment.
› Verified 6 days ago
Robert J Brumback, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
Dr. Milford Howarth Marchant Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 S Hanover St, Baltimore, MD 21225 Phone: 410-350-8336 Fax: 410-350-7178 | |
Dr. Michelle Ghert, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St Fl 6, Baltimore, MD 21201 Phone: 614-397-2721 | |
Henry R Boucher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
John J Carbone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3001 S Hanover St, Gruehn Bldg, Ste 502, Baltimore, MD 21225 Phone: 410-350-8300 | |
Dr. Dawn Laporte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Rm 5210, Baltimore, MD 21287 Phone: 410-955-3134 | |
Paul C Mcafee, M.D., MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St Ste 655, Baltimore, MD 21218 Phone: 410-554-2175 Fax: 410-554-2917 |